Literature DB >> 17145274

A 10-year retrospective study of inpatient adolescents with schizophrenia/schizoaffective disorder and substance use.

Gal Shoval1, Gil Zalsman, Alan Apter, Robyne Diller, Leo Sher, Abraham Weizman.   

Abstract

The comorbidity of schizophrenia/schizoaffective disorder and substance use is a major psychiatric concern that is associated with aggressive and suicidal behavior. This study investigated the clinical correlates and characterizes adolescent psychotic inpatients with and without comorbid substance use. We performed a retrospective study of 188 adolescent inpatients who were admitted between the years 1994 and 2004 to the inpatient unit of Geha Mental Health Center and who were diagnosed as suffering from either schizophrenia or schizoaffective disorder. The substance-using psychotic inpatients were found to have more relatives with substance-related disorders, fewer comorbid anxiety disorders, lower scores on the Brief Psychiatric Rating Scale and Hamilton Scale for Depression, higher scores on the Overt Aggression Scale, and they were more suicidal than the nonsubstance using inpatients. Adolescent inpatients with schizophrenia and schizoaffective who use substances possess differential clinical characteristics and particular correlates that justify adopting a specific approach to this high-risk clinical subgroup.

Entities:  

Mesh:

Year:  2006        PMID: 17145274     DOI: 10.1016/j.comppsych.2006.05.002

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  6 in total

1.  The prevalence and clinical correlates of substance use disorders in patients with psychotic disorders from an Upper-Middle-Income Country.

Authors:  Henk S Temmingh; Sumaya Mall; Fleur M Howells; Goodman Sibeko; Dan J Stein
Journal:  S Afr J Psychiatr       Date:  2020-07-28       Impact factor: 1.550

2.  Associations between past alcohol, cannabis, and cocaine use and current schizotypy among first-degree relatives of patients with schizophrenia and non-psychiatric controls.

Authors:  Michael T Compton; Victoria H Chien; Annie M Bollini
Journal:  Psychiatr Q       Date:  2009-04-25

3.  Prevalence and clinical correlates of substance use disorders in South African Xhosa patients with schizophrenia.

Authors:  Henk Temmingh; Ezra Susser; Sumaya Mall; Megan Campbell; Goodman Sibeko; Dan J Stein
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-08-14       Impact factor: 4.328

4.  Correlates of schizophrenia spectrum disorders in children and adolescents cared for in community settings.

Authors:  Katie L Nugent; Amy M Daniels; Melissa J Azur
Journal:  Child Adolesc Ment Health       Date:  2011-08-05       Impact factor: 2.175

5.  Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives.

Authors:  Sari G Ferber; Reut Hazani; Gal Shoval; Aron Weller
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

Review 6.  Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review.

Authors:  Danielle Hen-Shoval; Aron Weller; Abraham Weizman; Gal Shoval
Journal:  Int J Environ Res Public Health       Date:  2022-01-04       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.